Use of cell-immune agent composition delivered via hepatic artery to treat liver cancers

TW202639148APending Publication Date: 2026-10-01NATIONAL DEFENSIVE MEDICAL CENTER
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114112176
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-03-28
Publication Date
2026-10-01

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

The present invention disclosed a pharmaceutical composition for treating liver cancers and its application, wherein the pharmaceutical composition comprises a first reagent and a second reagent, the first reagent being autologous immune cells, and the second reagent being immune checkpoint inhibitors, wherein the pharmaceutical composition is administered via hepatic artery injection.
Need to check novelty before this filing date? Find Prior Art